147 related articles for article (PubMed ID: 2002771)
1. The use of monoclonal antibodies and limited proteolysis in elucidation of structure-function relationships in proteins.
Wilson JE
Methods Biochem Anal; 1991; 35():207-50. PubMed ID: 2002771
[No Abstract] [Full Text] [Related]
2. High-throughput limited proteolysis/mass spectrometry for protein domain elucidation.
Gao X; Bain K; Bonanno JB; Buchanan M; Henderson D; Lorimer D; Marsh C; Reynes JA; Sauder JM; Schwinn K; Thai C; Burley SK
J Struct Funct Genomics; 2005; 6(2-3):129-34. PubMed ID: 16211509
[TBL] [Abstract][Full Text] [Related]
3. A rapid method for comparing monoclonal antibodies by limited proteolysis and electrophoresis.
Weissman D; Rothstein TL; Marshak-Rothstein A
Hybridoma; 1985; 4(4):329-39. PubMed ID: 3905580
[TBL] [Abstract][Full Text] [Related]
4. Identifying disordered regions in proteins by limited proteolysis.
Fontana A; de Laureto PP; Spolaore B; Frare E
Methods Mol Biol; 2012; 896():297-318. PubMed ID: 22821533
[TBL] [Abstract][Full Text] [Related]
5. Structure and function of proteins in G-protein-coupled signal transfer.
Helmreich EJ; Hofmann KP
Biochim Biophys Acta; 1996 Oct; 1286(3):285-322. PubMed ID: 8982287
[No Abstract] [Full Text] [Related]
6. Modeling studies of the change in conformation required for cleavage of limited proteolytic sites.
Hubbard SJ; Eisenmenger F; Thornton JM
Protein Sci; 1994 May; 3(5):757-68. PubMed ID: 7520312
[TBL] [Abstract][Full Text] [Related]
7. Selective detection of complementarity-determining regions of monoclonal antibody by limiting protease access to the substrate: nano-surface and molecular-orientation limited proteolysis.
Iwamoto N; Shimada T; Umino Y; Aoki C; Aoki Y; Sato TA; Hamada A; Nakagama H
Analyst; 2014 Feb; 139(3):576-80. PubMed ID: 24326404
[TBL] [Abstract][Full Text] [Related]
8. NMR solution structure of the angiostatic peptide anginex.
Arroyo MM; Mayo KH
Biochim Biophys Acta; 2007 May; 1774(5):645-51. PubMed ID: 17478129
[TBL] [Abstract][Full Text] [Related]
9. Use of monoclonal antibodies in studies of lipoprotein structure and function.
Schonfeld G; Tikkanen MJ; Hahm KS
Adv Exp Med Biol; 1985; 183():135-57. PubMed ID: 2412411
[TBL] [Abstract][Full Text] [Related]
10. [Limited proteolysis of human leukocyte interferon-alpha2 and localization of the antigenic determinant binding the monoclonal antibodies].
Kostrov SV; Chernovskaia TV; Khodova OM; Borukhov SI; Ryzhavskaia AS
Biokhimiia; 1985 Nov; 50(11):1859-65. PubMed ID: 2415171
[TBL] [Abstract][Full Text] [Related]
11. Expanding the natural repertoire of protein structure and function.
Anthony-Cahill SJ; Magliery TJ
Curr Pharm Biotechnol; 2002 Dec; 3(4):299-315. PubMed ID: 12463414
[TBL] [Abstract][Full Text] [Related]
12. An antigenic determinant common to human chorionic somatomammotropin and human growth hormone revealed by limited proteolysis of immune complexes.
Santucci A; Rustici M; Bracci L; Neri P
Biopolymers; 1991 Aug; 31(9):1029-35. PubMed ID: 1723898
[TBL] [Abstract][Full Text] [Related]
13. Predicting protein function from sequence and structure.
Lee D; Redfern O; Orengo C
Nat Rev Mol Cell Biol; 2007 Dec; 8(12):995-1005. PubMed ID: 18037900
[TBL] [Abstract][Full Text] [Related]
14. Structure-function relationships in UCP1, UCP2 and chimeras: EPR analysis and retinoic acid activation of UCP2.
Chomiki N; Voss JC; Warden CH
Eur J Biochem; 2001 Feb; 268(4):903-13. PubMed ID: 11179956
[TBL] [Abstract][Full Text] [Related]
15. Structure and function of LIM domains.
Jurata LW; Gill GN
Curr Top Microbiol Immunol; 1998; 228():75-113. PubMed ID: 9401203
[No Abstract] [Full Text] [Related]
16. Monoclonal and polyclonal antibodies to human progesterone receptor peptide-(533-547) recognize a specific site in unactivated (8S) and activated (4S) progesterone receptor and distinguish between intact and proteolyzed receptors.
Traish AM; Wotiz HH
Endocrinology; 1990 Sep; 127(3):1167-75. PubMed ID: 2201532
[TBL] [Abstract][Full Text] [Related]
17. Amino acid sequence restriction in relation to proteolysis.
Jörnvall H; Persson B
Biosci Rep; 1983 Mar; 3(3):225-32. PubMed ID: 6407541
[TBL] [Abstract][Full Text] [Related]
18. Use of antibodies in the study of protein structure and function in lung diseases.
Miller EJ; Cohen AB
Am J Physiol; 1991 Feb; 260(2 Pt 1):L1-12. PubMed ID: 1705102
[TBL] [Abstract][Full Text] [Related]
19. Protein fragment domains identified using 2D gel electrophoresis/MALDI-TOF.
Person MD; Shen J; Traner A; Hensley SC; Lo HH; Abbruzzese JL; Li D
J Biomol Tech; 2006 Apr; 17(2):145-56. PubMed ID: 16741242
[TBL] [Abstract][Full Text] [Related]
20. Refining structural and functional predictions for secretasome components by comparative sequence analysis.
Mushegian A
Proteins; 2002 Apr; 47(1):69-74. PubMed ID: 11870866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
